Select a study name to view presentation slides and summary slides as they become available.
| Hot Line I – Late Breaking Trials on Prevention of Heart Failure: | |
 | PURE Patterns of risk factor prevalence for CVD globally by urbanization, gender, and economic status of countries and individuals: The Prospective Urban Rural Epidemiologic (PURE) Study of 153,996 people from 628 communities in 17 countries Salim Yusuf, Hamilton, Ontario, Canada Presentation slides | Summary slide |
 | DeFACTO Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography James Min, Los Angeles, Calif., U.S. Presentation slides | Summary slide |
 | ALTITUDE ALiskiren Trial In Type 2 Diabetes Using cardio-renal Endpoints Hans Henrik Parving, Copenhagen, Denmark Summary slide |
 | TRILOGY-ACS |
 | PARAMOUNT Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Patients with Heart Failure and Preserved Ejection Fraction: Primary Results from the PARAMOUNT Study Scott Solomon, Boston, Mass., U.S. Summary slide |
 | Aldo-DHF Aldosterone Receptor Blockade in Diastolic Heart Failure Burkert Mathias Pieske, Graz, Austria Summary slide |
| Clinical Trial and Registry Updates I – Updates on Prevention and Markers | |
| PRoFESS Impact of resting heart rates on recurrent stroke, cardiovascular outcomes, disability and cognitive decline in 20.165 patients after ischemic stroke Michael Boehm, Homburg/Saar, Germany | |
 | CLARIFY Women and men with stable coronary artery disease have similar cardiovascular outcomes: observations from an international prospective cohort of 30 977 patients from 45 countries Philippe Gabriel Steg, Paris, France Presentation slides |
| HPS2-THRIVE Treatment of HDL to Reduce the Incidence of Vascular Events Jane Armitage, Oxford, Great Britian Presentation slides | |
 | TRA 2°P-TIMI 50 Trial Vorapaxar for Secondary Prevention after Myocardial Infarction Benjamin Morgan Scirica, Boston, Mass., U.S. Presentation slides |
 | PURE Prevalence, awareness, treatment and control of hypertension in 600 urban and rural communities from 17 high, middle and low income countries: Results from the PURE (Prospective Urban Rural Epidemiology) Rafael Diaz, Rosario, Argentina Presentation slides |
